Featured
Last news
From Hype to Commercial Reality: ABI Research Reveals 60 Technology Predictions for 2027, Including AI Data Center Consolidation and Robotics Growth
As technology moves from promise to practical application, ABI Research predicts 2027 will be less about what technology can do and more about what it can deliver.
Modulate Accelerates Enterprise Voice AI With Twilio Ventures Investment and New Real-Time Audio Intelligence Capabilities
New synthetic voice detection technology identifies AI-generated callers in 1.6 seconds, while expanded Velma models give enterprises greater visibility into voice agent performance
Ondas Receives Purchase Order for Next-Generation Tactical Attack Drones, Aims to Leverage Planned ARAN Defense Acquisition to Manufacture Thousands of Systems
Following previously announced Digital Bat program award, Ondas advances toward production of low-cost tactical attack drones, targeting market opportunity with potential demand for tens of thousands of systemsPlanned acquisition of ARAN Defense expected to support establishment of a dedicated production line, strengthening Ondas' Precision Strike segment and scalable manufacturing capabilities
Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
HOUSTON, TX / ACCESS Newswire / November 10, 2026 / Stabilis Solutions, Inc., ("Stabilis" or the "Company") (Nasdaq:SLNG), a leading provider of clean fueling, production, storage, and last mile delivery solutions, today announced a three-year take-or-pay LNG supply agreement with an existing commercial aerospace customer in support of its operations at the John C. Stennis Space Center in Hancock County, Mississippi. The take-or-pay commitment covers January 1, 2027 through December 31, 2029. Under the agreement, the customer will purchase its LNG requirements at the site from Stabilis, with a minimum commitment of 230,000 gallons per month and monthly volumes of up to 260,000 gallons. Stabilis expects to supply the customer primarily from its owned liquefaction facility in Port Allen, Louisiana. Stabilis has supplied LNG to the customer at Stennis since 2024.
ACCESS Newswire Reports Third Quarter 2026 Results
Gross margin expands to 75% and Adjusted EBITDA margin reaches 15% as cash flow from operations continues to improveAverage ARR for subscriptions per customer at the end of Q3 2026 was $12,331, up from $11,651 at the end of Q3 2025Q3 2026 Adjusted EBITDA was $829,000 compared to $933,000 for Q3 2025Q3 2026 revenue decreased to $5.5M compared to $5.6M in Q2 2026 and $5.7M in Q3 2025Gross margin increased to 75% compared to 73% in Q2 2026 and consistent with Q3 2025Cash flow from operations was $469,000 compared to $173,000 in Q2 2026 and $(582,000) in Q3 2025
T4 Robotics Appoints Paul Hughes as Co-CEO and Announces Expansion into Unmanned Maritime Systems
Company expands its autonomous defense strategy into the maritime domain with development of its first unmanned surface vehicle concept, "Toe-biter"
ClearSign Receives Order for "M1" Series Burner from Tulsa Heaters Midstream (THM)
Fifth Burner Sold through THM for West Texas
Innovative Menopause Medicine from JASTLabs Advances Patent Protection Internationally
Independent review produces positive findings for JASTLabs patent claims; National filings phase begins for global markets.
Peraso to Showcase DUNE 60 GHz Wireless Platform at Africa Tech Festival 2026
Company to highlight license-free mmWave technology for expanding high-capacity broadband connectivity across Africa
ATWEC Technologies, Inc. (OTCID:ATWT) Reports Third Quarter 2026 Revenue of $12.46 Million, Up 37% Year-over-Year
Q3 Revenue Surges $3.37 Million Over Q3 2025 and Beats the Company's Own $10 Million Projection by More Than 24%; July Revenue Up 50% Year-over-Year
Nextech3D.ai to Report Fiscal Second Quarter 2027 Financial Results and Host Investor Webinar on November 19, 2026 at 4:30 PM ET
TORONTO, ON, AND NEW YORK, NY / ACCESS Newswire / November 10, 2026 / Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:1SS), an AI-first technology company focused on event technology and enterprise software, today announced that it will report financial results for its fiscal second quarter ended September 30, 2026, after market close on Thursday, November 19, 2026, at 4:30 PM ET. Evan Gappelberg, Chief Executive Officer and Anum Waqas, Chief Financial Office will host the live investor webinar.
China Explores a New Pathway for Medical AI: Bridging R&D Innovation and Clinical Adoption
DIAGENS (HKEX:02526.HK) advances an innovative model to lower barriers for specialised medical imaging AI development and real-world clinical implementation.
Geek+ Unveils 24/7 Warehouse Autonomy Plan to Advance Self-Optimizing, Around-the-Clock Operation
The roadmap brings together embodied AI, warehouse intelligence and globally deployed robotics to support the next generation of autonomous warehouse operations.
Precigen Posts Strong Q3: PAPZIMEOS Net Revenue Rose 37%; Positive Cash Flow Achieved Ahead of Schedule
Widespread adoption underwayFive-year data suggest lasting disease control and prolonged freedom from surgeryNew competing product said to face substantial uncertaintyBiotech in the News: The Longview
New Gold IRA Investing Guide Explains How to Buy Gold in an IRA for American Consumers
Learn how to buy gold in IRA through IRAEmpire's new Gold IRA investing guide for Americans.
Sweet As app launches restaurant discovery platform
Tired of Google and Instagram serving the same predictable restaurant recommendations? Or waiting on friends to finally text back with a suggestion?
Nvidia chief faces inquiry after disclosing affair with suspected Chinese agent
Jensen Huang, CEO of tech giant Nvidia, has publicly admitted to an affair with a suspected Chinese spy. The company is one of the most valuable in the world and is at the centre of China's AI race, producing the most advanced AI chips ever seen.
Nvidia CEO Jensen Huang Admits Infidelity Amid Spy Investigation
Nvidia chief executive Jensen Huang has publicly admitted to having a romantic relationship with an alleged Chinese intelligence agent, issuing a personal apology to his family as the company’s board of directors initiates an independent investigation into the matter. The admission follows intense scrutiny from US lawmakers regarding Huang's interactions and Nvidia's lobbying efforts for relaxed chip export policies to China.
Envision Deploys World’s First Commercial 800V DC Power System for AI Data Centers
Envision Energy has announced the commercial operation of a world-first integrated 800-volt direct-current power system at an artificial intelligence facility in Inner Mongolia. The deployment at the Galaxy AI campus utilizes a solid-state transformer to streamline power delivery, aiming to enhance electrical efficiency and reduce material requirements for rapidly expanding data centers.
Peraso to Announce 3Q 2026 Financial Results - Nov 12
SAN JOSE, CA / ACCESS Newswire / November 9, 2026 / Peraso Inc. (NASDAQ:PRSO) ("Peraso" or the "Company"), a leader in mmWave wireless technology solutions, today announced the Company will release its third quarter 2026 financial results on Thursday, November 12, 2026, after the market close, followed by a conference call at 5:00 p.m. Eastern Time to discuss the Company's results and business outlook.
Route1 Reports Third Quarter 2026 Results
Gross Profit and Adjusted EBITDA Increase as Gross Margin Reaches 49%; Recurring Revenue Grows 37% Year Over Year
Amdocs Named a Leader in the 2026 Gartner(R) Magic Quadrant(TM) for CSP AI-Enabled Marketing and Sales Solutions
JERSEY CITY, NJ / ACCESS Newswire / November 9, 2026 / Amdocs (NASDAQ:DOX) today announced that it has been recognized as a Leader in the inaugural Gartner® Magic Quadrant™ for CSP AI-Enabled Marketing and Sales Solutions, based on its Completeness of Vision and Ability to Execute.
Pacific Edge Labs Publishes More Than 120 Independent Lab Reports, Each Listed With the Testing Lab's Own ID
Researchers can see which laboratory tested each lot and check the report with that lab before ordering, on the company's official site, pacificedgelabs.io.
Regentis Signs Exclusive Distribution Agreement with AMI Technologies to Commercialize GelrinC(R) in Israel
Agreement with Israel's leading orthopedics distributor includes minimum purchase commitments; Revenue contributions expected to begin during 2027AMI Technologies brings an established orthopedic sales and distribution network with strong ties to leading surgeons serving leading Israeli hospitals and clinics.GelrinC is approved in Israel and Europe for knee cartilage repair, and is currently in a pivotal U.S. Phase III trial
Shelfietech Launched New Retail Software Platform
TEL AVIV, IL / ACCESS Newswire / November 9, 2026 / Shelfietech Ltd. (CSE:SHLF)(OTCQB:SHLFF) ("Shelfie" or the "Company") today announced the official launch of its new retail software platform, introducing a suite of AI-powered features that together form a new Call to Action layer. The platform turns retail data into real-time recommendations and clear next steps across customer management and consumer insights, inventory management and product availability, dynamic pricing and price optimization, and sales and operational performance measurement. By identifying where action is needed and recommending what to do next, the platform helps retail teams prioritize and act on opportunities as they arise. The new platform is commercially ready and Shelfie intends to immediately offer the solution to its customers.
Hancock Health Expands Robot Specimen Delivery to Parkway Building, Adding Scheduled and On-Demand Runs to the Lab
A robot will pick up specimens from a new Arrive Point™ at Parkway and carry them to the Hancock Regional Hospital laboratory several times a day
IGC Pharma Reports Third Quarter 2026 Financial Results and Provides Business Update
CALMA randomized 170 participants; topline results expected following last patient- last dose, database lock and unblinding
Ai4 Celebrates Successful Debut of Applied AI Research Conference (AAIRC), Bridging Academic Research and Industry Innovation
Ai4 Connects 700 Academic and Industry Attendees Through Double-Blind Peer-Reviewed Research with Real-World Business Applications
Nextech3D.ai Closes $720,000 Management-Led Private Placement
CEO Evan Gappelberg and CFO Anum Waqas invest more than $400,000 combined, representing over half of the offering
Hillcrest and Equipmake Sign Definitive Agreement to Jointly Develop and License ZVS Inverter Technology for Heavy-Duty Electric Vehicles
VANCOUVER, BC / ACCESS Newswire / November 9, 2026 / Hillcrest Energy Technologies Ltd. (CSE:HEAT)(OTCQB:HLRTF)(FSE:7HI) ("Hillcrest" or the "Company") has signed its first definitive commercial licensing agreement. Under a Technology Collaboration Agreement ("Agreement") with UK drivetrain manufacturer Equipmake Limited ("Equipmake"), a subsidiary of Equipmake Holdings plc (AQSE:EQIP), the companies will jointly develop an 800-volt traction inverter using Hillcrest's Zero Voltage Switching ("ZVS") technology for heavy-duty trucks, buses and off-highway equipment. If the inverter meets agreed acceptance criteria, Equipmake will hold exclusive rights to manufacture and sell it in those markets and will pay Hillcrest a royalty on net sales. The Agreement is Hillcrest's first definitive commercial licensing agreement.
Opti Digital Launches NEXA, an AI-Powered Intelligence Layer
The new intelligence layer connects signals across Opti Digital's platform, helping publisher teams prioritise what matters, understand performance and identify the next best action.
DataMEDS AI Announces Corexa Pharmacy's First Commercial Sale of Compounded Peptides Under FDA Enforcement Discretion Policy
TAMPA, FL / ACCESS Newswire / November 9, 2026 / DataMeds AI, Inc. ("DataMeds SI," "DataMEDS" or the "Company") (NASDAQ:MEDS), a healthcare company that integrates its health information technology and physical infrastructure with its EinsteinRx™ artificial intelligence platform and PharmacyChain™ blockchain-enabled smart contracts platform, today announced that its Corexa Pharmacy subsidiary has completed its first commercial sale of one of the six peptides (BPC-157, TB-500, KPV, MOTS-c, Epitalon and Semax, together the "Six Peptides") recommended by the U.S. Food and Drug Administration's (FDA) Pharmacy Compounding Advisory Committee (PCAC) at its July 23-24, 2026 meeting, in accordance with U.S. Health and Human Services' (HHS) Enforcement Discretion Policy (EDP). The Six Peptides are compounded drugs, are not FDA-approved and have not been evaluated by FDA for safety or efficacy.